Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness.
Ribero S, Galli F, Osella-Abate S, Bertero L, Cattaneo L, Merelli B, Tondini C, Ghilardi L, De Giorgi V, Occelli M, Quaglino P, Cassoni P, Palmieri G, Massi D, Mandala M; Italian Melanoma Intergroup. Ribero S, et al. Among authors: palmieri g. J Am Acad Dermatol. 2019 Jan;80(1):99-105.e5. doi: 10.1016/j.jaad.2018.06.054. Epub 2018 Nov 14. J Am Acad Dermatol. 2019. PMID: 30447951
Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon.
Ascierto PA, Daponte A, Parasole R, Perrone F, Caracò C, Melucci M, Palmieri G, Napolitano M, Mozzillo N, Castello G. Ascierto PA, et al. Among authors: palmieri g. Cancer. 2000 Oct 1;89(7):1490-4. doi: 10.1002/1097-0142(20001001)89:7<1490::aid-cncr11>3.0.co;2-v. Cancer. 2000. PMID: 11013362 Clinical Trial.
Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy.
Casula M, Colombino M, Satta MP, Cossu A, Lissia A, Budroni M, Simeone E, Calemma R, Loddo C, Caracò C, Mozzillo N, Daponte A, Comella G, Canzanella S, Guida M, Castello G, Ascierto PA, Palmieri G; Italian Melanoma Intergroup. Casula M, et al. Among authors: palmieri g. Eur J Cancer. 2007 Jan;43(1):137-43. doi: 10.1016/j.ejca.2006.07.017. Epub 2006 Oct 19. Eur J Cancer. 2007. PMID: 17055252
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
Ghiorzo P, Pastorino L, Pizzichetta MA, Bono R, Queirolo P, Talamini R, Annessi G, Bruno W, Nasti S, Gargiulo S, Battistuzzi L, Sini MC, Palmieri G, Scarrà GB; Italian Melanoma Intergroup. Ghiorzo P, et al. Among authors: palmieri g. Melanoma Res. 2009 Jun;19(3):142-5. doi: 10.1097/CMR.0b013e32832a1e18. Melanoma Res. 2009. PMID: 19339902
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma.
Colombino M, Capone M, Lissia A, Cossu A, Rubino C, De Giorgi V, Massi D, Fonsatti E, Staibano S, Nappi O, Pagani E, Casula M, Manca A, Sini M, Franco R, Botti G, Caracò C, Mozzillo N, Ascierto PA, Palmieri G. Colombino M, et al. Among authors: palmieri g. J Clin Oncol. 2012 Jul 10;30(20):2522-9. doi: 10.1200/JCO.2011.41.2452. Epub 2012 May 21. J Clin Oncol. 2012. PMID: 22614978
Diagnostic services for melanoma in Italy.
Stanganelli I, Ascierto P, Bono R, De Giorgi V, Pimpinelli N, Chiarion-Sileni V, Palmieri G, Pizzichetta MA, Testori A. Stanganelli I, et al. Among authors: palmieri g. Dermatology. 2013;226 Suppl 1:3-6. doi: 10.1159/000348860. Epub 2013 May 29. Dermatology. 2013. PMID: 23736263
Impact of mole mapping in the Italian health system.
Stanganelli I, Ascierto P, Bono R, De Giorgi V, Pimpinelli N, Chiarion-Sileni V, Palmieri G, Pizzichetta MA, Testori A. Stanganelli I, et al. Among authors: palmieri g. Dermatology. 2013;226 Suppl 1:13-7. doi: 10.1159/000348863. Epub 2013 May 29. Dermatology. 2013. PMID: 23736265
1,188 results